Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Product/R&D News
 
BMS's Phase 3 Trial of All-Oral Chronic HCV Regimen Shows High Cu... 2/22/2016
Amarantus Granted Chinese Patent Covering Use of MANF for Parkins... 2/2/2016
USFDA Clears BeiGene's IND for Clinical Development of Anti-PD-1 ... 1/15/2016
CANbridge Completes Chinese Glioblastoma Biomarker Study for Lead... (free) 1/7/2016
New Treatment for Alzheimer's Disease Enter Clinical Trial in Chi... 1/6/2016
Yisheng Biopharma Reports Positive Phase I Results for New Rabies... 1/4/2016
BeyondSpring Pharma Approved by CFDA to Initiate Global Phase III... 12/22/2015
Chi-Med Initiates Phase III Trial of Sulfatinib for NETs in China... 12/18/2015
Sinovac Approved to Initiate Clinical Trials of sIPV 12/11/2015
Chi-Med Initiates Phase III Trial of Fruquintinib for NSCLC in Ch... 12/8/2015
Shanghai Synthetic Biology Innovation Alliance Established 12/4/2015
Nature's White Paper - Turning Point: Chinese Science in Transiti... 12/3/2015
TaiGen's IV Taigexyn Achieved Primary Endpoint in Phase 3 Trial f... 12/3/2015
CFDA Approves EV71 Vaccine against HFMD 12/3/2015
HUYA Bioscience Announces Strategic Alliance With KDDF (free) 12/1/2015
China and New Zealand to Establish a Joint Medical Research Cente... (free) 11/16/2015
OncBioMune Granted Chinese Patent for Its Novel Cancer Vaccine 11/12/2015
Domestic Companies Step Up Development of AD Drugs 11/4/2015
British and Chinese Universities Sign MOU for Cancer Research Par... 10/22/2015
Review of Drug Registration Applications in Q3/2015 10/21/2015
Aoxing Pharma Receives China FDA Approval to Initiate Four Progra... 10/20/2015
Review of Drug Registration Applications in H1/2015 10/19/2015
CASI's Anticancer Gets Orphan Drug Designation from EMA 10/15/2015
iBio Announces New Chinese Patent for iBioModulate Portfoilio 10/13/2015
Ark Biosciences Announces Completion of Phase I Trials of Roche-l... 10/12/2015
USFDA Confirms Luye Pharma's NDA Submission for LY03004 Without A... 10/9/2015
RXi Pharma Granted Chinese Patent for Fibrosis Drug Candidate RXI... 9/29/2015
RuiYi Announces the First Human Dosing of a Novel Antibody, Geril... 9/22/2015
HUYA Bioscience International Announces Epigenetic Breast Cancer ... 9/10/2015
Chinese Scientists Develops A New Aborted Fetal Cell Line Walvax ... 9/10/2015
Page:2/3    Total number of articles:61  :[1][2][3]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links